10x Genomics, Inc. Class A Share Price
NASDAQ: TXG | Mid Cap10x Genomics, Inc. Class A Stock Performance
Open $45.16 | Prev. Close $45.51 | Circuit Range N/A |
Day Range $44.82 - $51.92 | Year Range $11.19 - $51.92 | Volume 2,73,378 |
Average Traded $49.06 |
10x Genomics, Inc. Class A Share Price Today
As of 10 August 2026, 10x Genomics, Inc. Class A's share price is $52.15. The stock opened at $45.16, compared to its previous close of $45.51. During today's trading session, 10x Genomics, Inc. Class A's share price traded between $44.82 and $51.92, with an average price of $48.37. Over the past 52 weeks, the stock has recorded a high of $51.92 and a low of $11.19. In terms of performance, 10x Genomics, Inc. Class A's share price has risen by 126.15% over the last six months and is up 272.23% on a year-on-year basis.
10x Genomics, Inc. Class A Share Price Chart
10x Genomics, Inc. Class A Stock Fundamentals & Key Indicators
Market Cap $6.51B | PE Ratio (TTM) -149.00 | Dividend Yield N/A |
EPS (TTM) $-0.35 | Revenue (TTM) $642.82M | Return On Equity (TTM) -5.47% |
Profit Margin -6.77% | Debt to Equity 0.19 | Quarterly Earnings Growth YoY 23.16% |
10x Genomics, Inc. Class A Quarterly Profit & Loss
All figures in USD
10x Genomics, Inc. Class A Annual Profit & Loss
All figures in USD
About 10x Genomics, Inc. Class A
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomics, Inc. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $46.66 | $52.15 | +10.39% |
Jul 2026 | $38.39 | $47.24 | +23.12% |
Jun 2026 | $28.04 | $38.37 | +35.44% |
May 2026 | $22.01 | $28.33 | +28.48% |
Apr 2026 | $21.80 | $22.05 | +3.91% |
Mar 2026 | $22.47 | $21.22 | -7.98% |
Feb 2026 | $20.02 | $23.06 | +14.16% |
Jan 2026 | $16.31 | $20.20 | +23.86% |
Dec 2025 | $18.31 | $16.31 | -13.48% |
Nov 2025 | $13.57 | $18.85 | +38.40% |
Oct 2025 | $11.74 | $13.62 | +16.51% |
Sep 2025 | $13.75 | $11.69 | -16.56% |
TXG Share Price FAQs
What is 10x Genomics, Inc. Class A share price today?
What is the 52 week high and 52 week low of 10x Genomics, Inc. Class A stock?
What is TXG's market capitalisation today?
What is TXG's net income for the last quarter?
What is the 5 year returns of TXG?
What is the high & low stock price of TXG today?
Can I buy TXG shares in India?